JPMorgan Chase & Co’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.1K | Buy |
13,056
+463
| +4% | +$2.45K | ﹤0.01% | 4954 |
|
|
2025
Q1 | $103K | Sell |
12,593
-40,113
| -76% | -$327K | ﹤0.01% | 4725 |
|
|
2024
Q4 | $675K | Buy |
52,706
+20,362
| +63% | +$261K | ﹤0.01% | 4022 |
|
|
2024
Q3 | $347K | Buy |
32,344
+8,985
| +38% | +$96.3K | ﹤0.01% | 4212 |
|
|
2024
Q2 | $185K | Buy |
23,359
+13,075
| +127% | +$104K | ﹤0.01% | 4310 |
|
|
2024
Q1 | $165K | Sell |
10,284
-6,344
| -38% | -$102K | ﹤0.01% | 4527 |
|
|
2023
Q4 | $228K | Sell |
16,628
-433
| -3% | -$5.94K | ﹤0.01% | 4379 |
|
|
2023
Q3 | $249K | Sell |
17,061
-2,431
| -12% | -$35.5K | ﹤0.01% | 4112 |
|
|
2023
Q2 | $332K | Buy |
19,492
+12,846
| +193% | +$219K | ﹤0.01% | 3984 |
|
|
2023
Q1 | $93K | Buy |
+6,646
| New | +$93K | ﹤0.01% | 4680 |
|
|
2022
Q2 | – | Sell |
-17,501
| Closed | -$149K | – | 5848 |
|
|
2022
Q1 | $149K | Sell |
17,501
-50,529
| -74% | -$430K | ﹤0.01% | 4577 |
|
|
2021
Q4 | $815K | Buy |
68,030
+17,902
| +36% | +$214K | ﹤0.01% | 3799 |
|
|
2021
Q3 | $889K | Buy |
50,128
+40,962
| +447% | +$726K | ﹤0.01% | 3683 |
|
|
2021
Q2 | $188K | Buy |
+9,166
| New | +$188K | ﹤0.01% | 4527 |
|
|
2020
Q3 | – | Sell |
-30,471
| Closed | -$931K | – | 4970 |
|
|
2020
Q2 | $931K | Buy |
30,471
+29,547
| +3,198% | +$903K | ﹤0.01% | 3052 |
|
|
2020
Q1 | $29K | Buy |
+924
| New | +$29K | ﹤0.01% | 4278 |
|